Joseph Rigdon to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Joseph Rigdon has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.216
-
Cohen JB, D'Agostino McGowan L, Jensen ET, Rigdon J, South AM. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding. J Hypertens. 2021 04 01; 39(4):795-805.
Score: 0.163
-
Vincent CL, Poehling KA, Rigdon J, Schaich CL, South AM, Downs SM. Cost-Effectiveness of Intensive Blood Pressure Control in Youth With Chronic Kidney Disease. Hypertension. 2025 Feb; 82(2):393-401.
Score: 0.053